ACE and heart failure: ACE inhibitors exhibit a favorable profile, which is convenient given their place in the current guidelines for hypertension and heart failure (2023 ESH Guidelines for the Management of Arterial Hypertension, Task Force for the Management of Arterial Hypertension of the European Society of Hypertension, 2024; McDonagh et al., 2021).